Hepatitis Delta Virus
Coinfection of hepatitis B and hepatitis Delta virus in Belgiumy: a multicenter BASL Study. Prospective epidemiolog and comparison with HBV mono-infection
... 6 Faculty of Medicine and Health Sciences, Gastroenterology/Hepatology, Antwerp University Hospital, Antwerp, Belgium Epidemiological data on hepatitis delta virus (HDV) infection in Belgium are ...
5
en fr Hepatitis delta virus replication and the role of the small hepatitis delta protein S-HDAg Réplication du génome du virus de l’hépatite delta : un rôle pour la petite protéine delta S-HDAg
... Le virus de l’hépatite delta, aussi appelé virus de l’hépatite D ou HDV, est un agent viral défec- tif à ARN de polarité ...autre virus, le virus de l’hépatite B (HBV), qui lui fournit ...
10
Le virus de l’hépatite Delta - Un agent pathogène qui retourne facilement sa veste ?
... autres virus humains, mais également pour recueillir des don- nées chez les patients afin d’anticiper la survenue de nouvelles maladies impli- quant VHD, ou une aggravation possible de celles qui sont déjà ...The ...
3
CD81-receptor associations-impact for hepatitis C virus entry and antiviral therapies
... and virus-induced host cell signaling for entry of HCV ...the virus itself or by RTK signaling, provide a functional link between CD81 trafficking and CD81-CLDN1 association that are prerequisites of HCV ...
19
Chronic hepatitis C virus infection, a new cardiovascular risk factor?
... Immunodeficiency Virus (HIV), have been associated with the occurrence of cardiovascular ...manifestations. Hepatitis C virus (HCV) infection has been associated to a very large number of ...
20
Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C.
... However, HCV infection does not consistently induce marked inflammation [ 6 ], particu- larly in fibrosing cholestatic hepatitis C, a highly aggressive course that can occur after liver transplantation, when ...
21
View of New treatments for chronic hepatitis C virus infection
... du virus de génotype 1, l ’une aux États- Unis (PROVE 1) [1] et l ’autre en Europe (PROVE 2) [2] ont clairement montré la supériorité de la trithérapie par rapport à la ...un virus de génotype 1, rechuteurs ...
10
Hepatitis C Virus Infection, a New Modifiable Cardiovascular Risk Factor
... [126] Fletcher NF, Wilson GK, Murray J, Hu K, Lewis A, Reynolds GM, et al. Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 2012;142:634–643. [127] Roed T, ...
16
Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma
... HCV does not integrate its genetic material into the host genome, and therefore requires continuous replication to maintain chronic infection. Many host factors, playing essential roles in the HCV life cycle and immune ...
14
[Open Sesame: regulation of hepatitis C virus entry into hepatocytes].
... Le développement de criblages fonctionnels basés sur l’ARN interférant a représenté une avancée considérable dans la découverte de nouvelles interactions entre des virus et leurs cellules hôtes [6]. Au cours de ...
12
Evidence that hepatitis C virus genome partly controls infection outcome
... the virus genotype, as their presence appears to reduce opportunities to spread the ...between virus and host genotypes, and also into how these interactions affect the evolution of virulence and pathogen ...
16
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
... Chronic hepatitis B virus (HBV) infection is prevalent, deadly, and seldom cured due to the persistence of viral episomal DNA (cccDNA) in infected ...the virus and possibly cure ...
10
Host neutralizing responses and pathogenesis of hepatitis C virus infection.
... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignemen[r] ...
2
Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals
... Many controversies persist regarding the question of whether HCV coinfection increases T-cell activation or inflammation induced by HIV-1. Indeed, HCV is known to activate the liver type-I IFN pathway despite ...
13
Opening the door for hepatitis C virus infection in genetically humanized mice.
... For Peer Review Comment Hepatitis C virus (HCV) infection represents a major public health burden. While only a fraction of infected individuals is able to clear acute HCV infection spontaneously, the ...
13
Hepatitis C virus infection and chronic kidney disease: Time for reappraisal
... Abstract Hepatitis C virus (HCV) infection is associated with tremendous morbidity and mortality due to liver complications. HCV infection is also associated with many extrahepatic manifestations including ...
31
Seroprevalence of hepatitis E virus among blood donors on Corsica, France, 2017
... Article submitted on 28 May 2019 / accepted on 04 Nov 2019 / published on 06 Feb 2020 Background: Hepatitis E virus (HEV) is an emerging zoonotic pathogen and an important cause of acute viral ...
10
en fr Immunotherapies of hepatocellular carcinoma and hepatitis C virus infection Développement d'immunothérapies du carcinome hépatocellulaire et de l'infection par le virus de l'hépatite C
... du virus et représentant de nouvelles cibles thérapeutiques prometteuses, d’autant plus que deux inhibiteurs de protéines kinases, l’erlotinib (inhibiteur de EGFR) et le dasatinib (inhibiteur de EphA2), sont déjà ...
193
Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins.
... Whereas hepatitis C virus (HCV) in cell culture has a density compatible with that of the Flaviviridae family, in vivo infectious particles are partly found in low density fractions, associated with ...
25
Relationship between humoral response against hepatitis C virus and disease overcome
... most of these studies have focused on the occurrence of Ab directed against different viral proteins without regards to their quantification. Moreover, they are often limited by the use of recombinant large proteins or ...
13